6 Recruiting Urothelial Cancer Phase 2 Clinical Trials
Active phase 2 studies for urothelial cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Urothelial Cancer studiesPhase 2 Studies for Urothelial Cancer
🔵 Active, Not Recruiting Phase2
A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer
📍 Cleveland Clinic — Cleveland, Ohio
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
📍 Clinical Research Facility — Sedona, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
📍 Research Site — Fullerton, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
📍 Local Institution - 0167 — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Sacituzumab Govitecan Plus EV in Metastatic UC
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔